Search
Zhiran Medical Completes RMB 300 Million Series A+ Financing
3 day ago /
Read about 0 minute
Author：小编
Recently, Zhiran Medical, a leading domestic invasive brain-computer interface enterprise, announced the completion of a RMB 300 million Series A+ financing round. This round was led by CAS Star, with continued participation from several existing investors, including Legend Capital, Beijing Healthcare Industry Investment Fund, and IDG Capital. The funds will primarily support the advancement of large-scale clinical trials and the iterative upgrade of high-throughput flexible brain-computer interface products, accelerating the translation of technology into clinical applications.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
